id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-341416-6bh08901	Smithgall, Marie C.	Laboratory Testing of SARS CoV-2: A New York Institutional Experience	2020-07-19		.txt	text/plain	2923	161	47	The World Health Organization developed the first quantitative RT-PCR test for detecting SARS-CoV-2 and subsequently the U.S. Centers for Disease Control and Prevention (CDC) began shipping its own RT-PCR test kits after receiving Emergency Use Authorization (EUA) by the U.S. Food and Drug Administration (FDA) on February 4, 2020. To date there are more than 80 commercial laboratories and/or test kit manufacturers that have received approval for emergency use by the Federal Drug Administration (FDA) for SARS-CoV-2 testing with molecular assays accounting for the vast majority [6] . In addition, the FDA recently granted EUA for an RT-PCR lab developed test for qualitative detection of SARS-CoV-2 in saliva specimens and a test that uses a home collection kit with nasal swabs [6] for details see https://www.fda.gov/emergency-preparednessand-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization]. During this time, termed the "window period," a patient who is infected with SARS-CoV-2, but has not yet produced antibodies, would test negative on such an assay.	./cache/cord-341416-6bh08901.txt	./txt/cord-341416-6bh08901.txt